Malvern Diabetic Foot Conference 2021
 

Rescheduled dates for the 18th Malvern Diabetic Foot Conference due to COVID-19

Wednesday, 12 May 2021 - Friday, 14 May 2021

The Malvern Diabetic Foot Conference is the longest standing,
biannual international diabetic foot meeting held in the UK.

In 1986, it was the very first multidisciplinary team foot conference held in the UK and
2021 will mark the 35th Anniversary of this extremely popular and well-attended event.

Many delegates and most sponsors who were attending the planned conference in 2020 have held their places for 2021. 
If you would like to join them, please REGISTER now.

 

 

This three day conference is designed to bring together physicians, surgeons, podiatrists, orthotists and nursing staff with a common interest in diabetic foot problems. It is anticipated that the conference will improve our understanding of this disease which represents one of the main causes for in-patient treatment amongst the diabetic population.
 

  • The attendance fee is £320.00 + VAT.

  • Places at the Conference Dinner are also available to pre-book at a cost of £35.00 + VAT.

  • Payment can be submitted during your online registration by Credit Card using PayPal.

An application for CPD approval will be submitted to the Federation of the Royal Colleges of Physicians of the United Kingdom.

In 2018 the 17th Malvern Diabetic Foot Conference welcomed over 300 speakers, sponsors and delegates, and we are expecting to replicate this success in 2021.

ADVANCE NOTICE

We'll be getting dates back on track in 2022 when the 19th Conference will take place from the 11thto 13th May -
thereafter the conference will continue to be held biennially.

 

If you have any questions please do not hesitate to e-mail thechairmen@malverndiabeticfoot.org or call the Event Team on +44 (0)1491 419800.

Malvern Diabetic Foot Conference
At the Limits Limited
Holly Tree Barn
Hambleden
Henley-on-Thames
Oxfordshire. RG9 6NB
UNITED KINGDOM

 

This meeting is supported by grants and sponsorship from the pharmaceutical and device industries. See here for details.